Published in Internist (Berl) on November 01, 1992
Calcium and fibre supplementation in prevention of colorectal adenoma recurrence: a randomised intervention trial. European Cancer Prevention Organisation Study Group. Lancet (2000) 3.26
European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG). Ann Oncol (2004) 2.65
Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: new perspectives 2006. Ann Oncol (2007) 2.05
Single-agent carboplatinum for advanced seminoma. A phase II study. Cancer (1993) 1.63
Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer. Ann Oncol (2012) 1.44
DEGRO practical guidelines: radiotherapy of breast cancer I: radiotherapy following breast conserving therapy for invasive breast cancer. Strahlenther Onkol (2013) 1.32
Treatment of localised prostate cancer with transrectal high intensity focused ultrasound. Eur J Ultrasound (1999) 1.23
Elastography for the follow-up of high-intensity focused ultrasound prostate cancer treatment: initial comparison with MRI. Ultrasound Med Biol (2005) 1.13
Treatment of prostate cancer with transrectal focused ultrasound: early clinical experience. Eur Urol (1996) 1.10
High-intensity focused ultrasound experimentation on human benign prostatic hypertrophy. Eur Urol (1993) 1.06
p53 overexpression is frequent in European hepatocellular carcinoma and largely independent of the codon 249 hot spot mutation. Oncogene (1994) 1.06
Para-aortic irradiation for stage I testicular seminoma: results of a prospective study in 675 patients. A trial of the German testicular cancer study group (GTCSG). Br J Cancer (2004) 1.04
1.5-D high intensity focused ultrasound array for non-invasive prostate cancer surgery. IEEE Trans Ultrason Ferroelectr Freq Control (2002) 1.02
Modeling of pulsed finite-amplitude focused sound beams in time domain. J Acoust Soc Am (1998) 1.01
DEGRO practical guidelines: radiotherapy of breast cancer III--radiotherapy of the lymphatic pathways. Strahlenther Onkol (2014) 0.99
Ultra-high-dose lanreotide treatment in patients with metastatic neuroendocrine gastroenteropancreatic tumors. Digestion (1999) 0.97
Decrease of natural killer cell activity and monokine production in peripheral blood of patients treated with recombinant tumor necrosis factor. Blood (1988) 0.96
One life saved by four prevented recurrences? Update of the Early Breast Cancer Trialists confirms: postoperative radiotherapy improves survival after breast conserving surgery. Strahlenther Onkol (2012) 0.95
Treatment of early stage testicular seminoma. J Cancer Res Clin Oncol (2001) 0.95
Computerized ultrasound B-scan texture analysis of experimental diffuse parenchymal liver disease: correlation with histopathology and tissue composition. J Clin Ultrasound (1991) 0.94
The humoral immune response to p53 in patients with hepatocellular carcinoma is specific for malignancy and independent of the alpha-fetoprotein status. Hepatology (1993) 0.93
Interdisciplinary consensus on diagnosis and treatment of testicular germ cell tumors: result of an update conference on evidence-based medicine (EBM). Eur Urol (2001) 0.92
A randomized trial of cisplatin, etoposide and bleomycin (PEB) versus carboplatin, etoposide and bleomycin (CEB) for patients with 'good-risk' metastatic non-seminomatous germ cell tumors. Ann Oncol (1996) 0.92
Pen-based remote data entry system. A pilot clinical trial. Arzneimittelforschung (1993) 0.87
Diagnostic reliability of somatostatin receptor scintigraphy during continuous treatment with different somatostatin analogs. Horm Metab Res Suppl (1993) 0.86
A phase I/II study of a stepwise dose-escalated regimen of cisplatin, etoposide and ifosfamide plus granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients with advanced germ cell tumours. Eur J Cancer (1993) 0.86
High-dose epirubicin + cyclophosphamide (HD-EC) in metastatic breast cancer: preliminary data of a phase-II study. Onkologie (1988) 0.85
Is the simultaneously integrated boost (SIB) technique for early breast cancer ready to be adopted for routine adjuvant radiotherapy? Statement of the German and the Austrian Societies of Radiooncology (DEGRO/ÖGRO). Strahlenther Onkol (2013) 0.85
High-dose epirubicin + cyclophosphamide (HD-EC) in metastatic breast cancer: a dose-finding study. Onkologie (1988) 0.84
Radiotherapy for stages I and IIA/B testicular seminoma. Int J Cancer (1999) 0.83
Visualisation of liver tumours using hand-held real-time strain imaging: results of animal experiments. Br J Radiol (2012) 0.83
Evaluation of the importance and relevance of dose intensity using epirubicin and cyclophosphamide in metastatic breast cancer: interim analysis of a prospective randomized trial. Semin Oncol (1994) 0.82
Radiotherapy with 16 Gy may fail to eradicate testicular intraepithelial neoplasia: preliminary communication of a dose-reduction trial of the German Testicular Cancer Study Group. Br J Cancer (2003) 0.82
[Determination of the carcinoembryonic antigen (CEA) for predicting the success of therapy in metastatic breast cancer]. Dtsch Med Wochenschr (1983) 0.82
False-negative biopsies for testicular intraepithelial neoplasia. J Urol (1999) 0.82
When are breast cancer patients old enough for the quitclaim of local control? Strahlenther Onkol (2012) 0.81
Tumor-associated antigens in effusions of malignant and benign origin. Clin Investig (1993) 0.81
Tumor regression of an ileal carcinoid under the treatment with the somatostatin analogue SMS 201-995. Klin Wochenschr (1988) 0.81
[Preliminary results of the treatment of 44 patients with localized cancer of the prostate using transrectal focused ultrasound]. Prog Urol (1998) 0.81
Phase-I trial of intravenous continuous infusion of tumor necrosis factor in advanced metastatic carcinomas. J Cancer Res Clin Oncol (1989) 0.80
Lack of association of Helicobacter pylori seroprevalence and gastric cancer in a population with low gastric cancer incidence. Scand J Gastroenterol (1995) 0.80
How nescience may obscure evidence. Strahlenther Onkol (2014) 0.80
Treatment of the carcinoid syndrome with a depot formulation of the somatostatin analogue lanreotide. Eur J Cancer (1994) 0.79
Intra-arterial perfusion therapy with 5-fluorouracil in patients with metastatic colorectal carcinoma and intractable pelvic pain. Recent Results Cancer Res (1983) 0.79
Contrast media for computer tomography of the liver. Acta Radiol Diagn (Stockh) (1980) 0.78
Actual management of ductal carcinoma in situ of the breast. Arch Gynecol Obstet (2009) 0.78
Analysis of an adaptive strain estimation technique in elastography. Ultrason Imaging (2002) 0.78
[Management of testicular intraepithelial neoplasia (TIN)--a review based on the principles of evidence-based medicine]. Wien Klin Wochenschr (2001) 0.78
[An interdisciplinary consensus conference on the diagnosis and therapy of testicular tumors]. Strahlenther Onkol (1997) 0.78
Surface coat of the palatal shelf epithelium during palatogenesis in mouse embryos. Anat Embryol (Berl) (1975) 0.78
[Follow-up of testicular germ cell cancer patients: interdisciplinary evidence-based recommendations]. Urologe A (2011) 0.78
Computerized ultrasound B-scan texture analysis of experimental fatty liver disease: influence of total lipid content and fat deposit distribution. Ultrason Imaging (1990) 0.78
Improved visualization of carcinoid liver metastases by indium-111 pentetreotide scintigraphy following treatment with cold somatostatin analogue. Eur J Nucl Med (1993) 0.78
Serum neopterin levels in lung and breast cancer patients undergoing radiotherapy and/or chemotherapy. Int J Biol Markers (1989) 0.77
High-intensity focused ultrasound transducers suitable for endoscopy: feasibility study in rabbits. Gastrointest Endosc (1997) 0.77
[Somatostatin receptor scintigraphy in the primary diagnosis and follow-up care of gastrinoma]. Dtsch Med Wochenschr (1994) 0.77
Phase II evaluation of carboplatin in advanced esophageal carcinoma. A trial of the Phase I/II Study Group of the Association for Medical Oncology of the German Cancer Society. Onkologie (1990) 0.77
[Somatostatin receptor scintigraphy. A new imaging procedure for the specific demonstration of carcinoids of the small intestine]. Rofo (1993) 0.76
Sequential methotrexate and 5-fluorouracil: improved response rate in metastatic colorectal cancer. J Clin Oncol (1984) 0.76
Preliminary results of a phase I/II trial of paclitaxel in patients with relapsed or cisplatin-refractory testicular cancer. J Cancer Res Clin Oncol (1994) 0.75
Optimizing treatment of seminoma stage IIA/B step by step. Ann Oncol (2013) 0.75
Tumour necrosis factor production and natural killer cell activity in peripheral blood during treatment with recombinant tumour necrosis factor. Br J Cancer (1989) 0.75
Phase II study of pirarubicin in metastatic breast cancer. Onkologie (1990) 0.75
Bone marrow transplantation in acute leukemia [proceedings]. Pathol Biol (Paris) (1978) 0.75
[First clinical experience with large volume plasma exchange in malignant tumor patients]. Schweiz Med Wochenschr (1980) 0.75
[Disease observations in hematologic system diseases (leukemia Waldenström's disease) and immunologic deficiencies using B- and T-cell specific markers]. Verh Dtsch Ges Inn Med (1974) 0.75
[Possibilities of plasmapheresis treatment of metastasizing malignomas]. Internist (Berl) (1983) 0.75
[Study about the healing of anastomoses in the irradiated colon--experimentation on animals (author's transl)]. Strahlentherapie (1982) 0.75
[Bone marrow transplantation for aplastic anaemia and acute leukaemia (author's transl)]. Dtsch Med Wochenschr (1982) 0.75
[Treatment of acute myeloblastic leukemias under sterile conditions using a laminar down-flow system for the pervention of infection in comparison with single-room treatment]. Verh Dtsch Ges Inn Med (1975) 0.75
Resistance of tumour cells to chemotherapy: importance of host defence factors. Cancer Treat Rev (1984) 0.75
[Plasmapheresis: First clinical results in malignant tumors]. Schweiz Med Wochenschr (1981) 0.75
Efficacy of large-volume plasma exchange in patients with chemotherapy-resistant metastatic colorectal cancer. Oncology (1985) 0.75
The use of RA 233 in the preparation of platelets, with the blood cell separator. Blut (1977) 0.75
[Roentgenologic contribution to the diagnosis of gallstone ileus]. Rofo (1983) 0.75
[Results of primary chemotherapy in 44 patients with advanced squamous cell carcinoma in the area of the head and neck]. HNO (1984) 0.75
[Additional experiences in the treatment of acute leukemias in the sterile laminar down-flow tents and in single rooms]. Verh Dtsch Ges Inn Med (1976) 0.75
[Cytostatic therapy of advanced squamous cell carcinoma of the head and neck. A randomized study comparing cis-dichlorodiammineplatinum(II) and bleomycin with methotrexate and vindesine]. Onkologie (1984) 0.75
[Late radiation damage in the intestine. Clinical aspects, therapy and prognosis (author's transl)]. MMW Munch Med Wochenschr (1981) 0.75
[Treatment of epidermoid head and neck cancer with cisplatinum/bleomycin vs methotrexate/vindesine]. Laryngol Rhinol Otol (Stuttg) (1981) 0.75
In vitro adsorption of colon cancer sera over staphylococcus protein A: lymphocyte stimulation by leakage of adsorbance. Klin Wochenschr (1987) 0.75
Immune complex-like material in the serum and plasma exchange in patients with metastatic cancer. Eur J Clin Invest (1984) 0.75
Serum blocking factors in tumor bearing hosts: the value of extended plasma exchange on in vitro immune parameters of patients with advanced cancer. Adv Exp Med Biol (1982) 0.75
[Anastomosis healing in the irradiated colon. II. Influence of irradiation on new formation of connective tissue. An animal experiment study]. Strahlentherapie (1983) 0.75
Treatment of polycythemia vera by isovolemic large-volume erythrocytapheresis. Klin Wochenschr (1990) 0.75
High-dose epirubicin in combination with cyclophosphamide (HD-EC) in advanced breast cancer: final results of a dose finding study and phase II trial. Onkologie (1990) 0.75
Chemotherapy of squamous head and neck cancer: a prospective randomized trial comparing cis-platinum and bleomycin with methotrexate and vindesine. Recent Results Cancer Res (1985) 0.75
[Testicular tumor--yesterday--today--tomorrow]. Urologe A (2006) 0.75
Glycoprotein-adsorption from cancer sera--influence on a mixed lymphocyte culture. J Clin Lab Immunol (1985) 0.75
[Late radiation damage to intestines following irradiation of gynaecological tumours (author's transl)]. Zentralbl Gynakol (1980) 0.75
The efficacy of large volume plasma exchange in chemotherapy resistant malignancies. Int J Artif Organs (1984) 0.75
The growth capacity of hematopoietic progenitor cells in severe neutropenia induced by famotidine. Ann Hematol (1992) 0.75
[The protective effect of hydroxyethylstarch (HES) in the cryoconservation of bone marrow of the mouse and of man (author's transl)]. Anaesthesist (1975) 0.75